-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
-
Summary
-
Lineage Cell Therapeutics, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from Q1 2011 to Q1 2024.
- Lineage Cell Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2024 was $38K, a 79.8% decline year-over-year.
- Lineage Cell Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $674K, a 63.2% increase from 2022.
- Lineage Cell Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $413K, a 21.5% increase from 2021.
- Lineage Cell Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $340K, a 431% increase from 2020.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)